Ameriprise
AMPE

Ameriprise’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Ameriprise’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-425
Closed -$959K – 4089
2015
Q1 		$959K Buy
+425
New +$725K ﹤0.01% 2973
2014
Q4 		– Hold
0
– – – 4573
2014
Q3 		– Hold
0
– – – 5926
2014
Q2 		– Hold
0
– – – 5683
2014
Q1 		– Hold
0
– – – 5423
2013
Q4 		– Sell
-6
Closed -$14.2K – 5480
2013
Q3 		$13K Hold
6
– – ﹤0.01% 4728
2013
Q2 		$10K Buy
+6
New +$9.53K ﹤0.01% 4790

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ameriprise's AMPE Position: Q2 2015 in Review

Ameriprise sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2015, closing a stake of 425 shares — an estimated $959K sold.

Ameriprise first reported a position in AMPE in Q2 2013 and held it in 3 quarters. The position peaked at $959K in Q1 2015. 64 funds tracked by Wall St. Rank hold AMPE as of Q2 2015.

  • Ameriprise reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
  • Ameriprise sold 425 Ampio Pharmaceuticals Inc. shares in Q2 2015, an estimated $959K.
  • Ameriprise first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 3 quarters.
  • Ameriprise's Ampio Pharmaceuticals Inc. position peaked at $959K in Q1 2015.
  • 64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2015.

Based on Ameriprise's 13F filing for Q2 2015, filed 13 Aug 2015.